Evidence map›Paper›PMID 25001011›Full record

ArticleDer Internist2014

[Standards for diagnostics and therapy of gastric cancer].

N Schulte, M Ebert

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Der Internist, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

N SchulteII. Medizinische Klinik, Universitätsmedizin Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland, nadine.schulte@umm.de.
M Ebert

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite a decreasing frequency gastric cancer is the fifth or sixth most common cancer in Germany. Usually the cancer is discovered in an advanced stage. This article is based primarily on the current S3 guidelines for gastric cancer published 2011. General aspects of risk factors, diagnosis and therapy with the current classification system are the main topics in this article. Furthermore, this article focuses on treatment of local advanced disease. Especially in recent years, many studies have dealt with the concept of perioperative treatment. However, a worldwide standard of care could not be reached for this indication.

Indexed as

Practice Guidelines as TopicDiagnostic ImagingGastroenterologyGermanyHumansMedical OncologyStomach Neoplasms

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.